The Biomarker Research Services Market - Introduction
Biomarkers are key molecular or cellular events that are used to link a specific environmental exposure to a health outcome or target disease. Biomarkers play an important role in understanding the development of chronic human diseases and identification of subgroups that are at increased risk for disease. In the past few years, biomarkers have been extensively used in all therapeutic areas of medicine to diagnose a particular disease. Biomarkers are used for drug approval process as included in the regulatory submission processes.
Biomarker research services are specifically provided for development and validation of new biomarkers. These services are provided for different purposes such as research assay, biomarker validation & discovery of a biomarker, qualification, verification, optimization, and companion diagnostics. Companion diagnostic (CDx) is a medical device or test used for a therapeutic drug to determine and validate its drug applicability in specific person, its safety, risk, and benefit from that drug.
The Biomarker Research Services Market – Competitive Landscape
The global biomarker research services market is highly fragmented due to presence of major companies and CROs. Key players operating in the global market include Noble Life Sciences, Inc., REPROCELL USA, Inc., BioIVT, Covance, Inc., PointCross Life Sciences, Coriell Institute, SRI International, ICON plc, Nordic Bioscience, and Proteome Sciences plc.
Identify the key factors that will drive your company’s growth. Request a brochure of this report here
Merger & acquisition, collaboration, strategic alliances, partnerships, and new product offerings are the key strategies adopted by the major companies.
- On 25 March 2019, BioIVT joined the Foundation for the National Institutes of Health (FNIH) Biomarkers Consortium to develop and support research to qualify promising biomarkers for diagnosing diseases, predicting therapeutic response, or improving clinical practice.
Noble Life Sciences, Inc.
Founded in 2010, Noble Life Sciences, Inc. is headquartered in U.S. Noble Life Sciences, Inc. is a contract research organization (CRO) which offers in-vitro and in-vivo preclinical drug development services. Company also offers standard GLP and non-GLP services which involves safety & efficacy testing for the development of drugs, vaccines and medical devices. Biomarker discovery & validation, molecular tumor profiling, and clinical biomarker development & implementation services are some of the major services provided by company.
REPROCELL USA, Inc.
Established in 2003, REPROCELL USA, Inc. is headquartered at Yokohama, Japan. REPROCELL USA, Inc. is a global company located at U.S., Europe, Japan and India. Company services include BioServe, predictive drug discovery custom services, stem cell culture media and reprogramming technologies.
In April 2017, REPROCELL and Fox Chase Cancer Center announced a strategic alliance aimed at accelerating oncology discovery and translational studies. This alliance aimed to accelerate biomarker and genetic discovery.
Founded in 1981, BioIVT is based in U.S. Company provides value-added services such as biomarker target & validation, precision medicine research and phenotypic assays. Company has acquired various other organizations to enhance its presence and services offered.
In August 2017, BioIVT acquired Asterand Bioscience, which focused on drug research by biomarker validation and target identification.
Established in 1996, Covance, Inc. is headquartered at Princeton, U.S. Covance, Inc. is a contract research organization and was acquired by Laboratory Corporation of America Holdings in 2014. Company offers nonclinical, preclinical and clinical services to pharmaceutical, and biotechnology companies for drug development, clinical testing, regulatory services and safety & toxicology studies.
Expanding operations in future? To get the perfect launch ask for a custom report here
Biomarker Research Services Market - Dynamics
Rise in prevalence of chronic diseases and growing use of biomarkers in diagnostic therapeutic areas driving the market
Increasing use of biomarkers in diagnostic therapeutic and rise in prevalence of chronic diseases across the world are the major factors boosting the growth of the global biomarker research services market. According to the WHO, cancer accounted for an estimated 9.6 million deaths and was the second major cause of death globally in 2018. Moreover, about 1 in 6 deaths occur due to cancer globally.
Major merger, acquisitions and strategic partnerships by major players to drive the global market
Mergers & acquisitions and strategic partnerships by key players are fueling the growth of the global biomarker research services market. Moreover, increase in therapeutic areas of companion diagnostics in personalized medicine is attributed to the growth of the global biomarker research services market. In April 2017, Bristol-Myers Squibb and Nordic Bioscience announced a collaboration agreement for biomarker development technology to potentially aid in the diagnosis and monitoring of fibrotic diseases.
Higher cost for research and incapability of pharmaceutical & biotechnology companies restraining biomarker research services market growth
Incapability of pharmaceutical & biotechnology companies to conduct biomarker research and higher cost for research are the factors likely to hamper the growth of the global biomarker research services market. Higher research cost for new drug development and drug discovery is hampering the growth of global biomarker research services market.
North America Biomarker research services market- Dominating region
North America dominated the global market in 2018 and is projected to sustain its position during the forecast period. Higher demand of biomarkers for disease diagnosis, companion diagnostic research for new drug development, rise in prevalence of chronic diseases, presence of major players engaged in mergers & acquisitions, collaboration with CROs for biomarkers, and rise in investment for R&D by companies are the major factors driving the biomarker research services market in North America.
Biomarker Research Services Market - Segmentation
The global biomarker research services market can be segmented on the basis of:
- Service Type
- Therapeutic Area
Biomarker Research Services Market Segmentation – By Service Type
Depending on the service type, the biomarker research services market can be divided into:
- Biomarker Research Services
- Companion Diagnostic Research Services
Biomarker Research Services Market Segmentation – By Therapeutic Area
Based on the therapeutic area, the biomarker research services market can be divided into:
- Cardiovascular Diseases
- Neurological Disorders
- Immunological Diseases
Biomarker Research Services Market Segmentation – By End-user
In terms of end-user, the biomarker research services market can be divided into:
- Hospitals & specialty clinics
- Diagnostic Centers
- Pharmaceutical & biotechnology companies
This study by TMR is all-encompassing framework of the dynamics of the market. It mainly comprises critical assessment of consumers' or customers' journeys, current and emerging avenues, and strategic framework to enable CXOs take effective decisions.
Our key underpinning is the 4-Quadrant Framework EIRS that offers detailed visualization of four elements:
- Customer Experience Maps
- Insights and Tools based on data-driven research
- Actionable Results to meet all the business priorities
- Strategic Frameworks to boost the growth journey
The study strives to evaluate the current and future growth prospects, untapped avenues, factors shaping their revenue potential, and demand and consumption patterns in the global market by breaking it into region-wise assessment.
The following regional segments are covered comprehensively:
- North America
- Asia Pacific
- Latin America
- The Middle East and Africa
The EIRS quadrant framework in the report sums up our wide spectrum of data-driven research and advisory for CXOs to help them make better decisions for their businesses and stay as leaders.
Below is a snapshot of these quadrants.
1. Customer Experience Map
The study offers an in-depth assessment of various customers’ journeys pertinent to the market and its segments. It offers various customer impressions about the products and service use. The analysis takes a closer look at their pain points and fears across various customer touchpoints. The consultation and business intelligence solutions will help interested stakeholders, including CXOs, define customer experience maps tailored to their needs. This will help them aim at boosting customer engagement with their brands.
2. Insights and Tools
The various insights in the study are based on elaborate cycles of primary and secondary research the analysts engage with during the course of research. The analysts and expert advisors at TMR adopt industry-wide, quantitative customer insights tools and market projection methodologies to arrive at results, which makes them reliable. The study not just offers estimations and projections, but also an uncluttered evaluation of these figures on the market dynamics. These insights merge data-driven research framework with qualitative consultations for business owners, CXOs, policy makers, and investors. The insights will also help their customers overcome their fears.
3. Actionable Results
The findings presented in this study by TMR are an indispensable guide for meeting all business priorities, including mission-critical ones. The results when implemented have shown tangible benefits to business stakeholders and industry entities to boost their performance. The results are tailored to fit the individual strategic framework. The study also illustrates some of the recent case studies on solving various problems by companies they faced in their consolidation journey.
4. Strategic Frameworks
The study equips businesses and anyone interested in the market to frame broad strategic frameworks. This has become more important than ever, given the current uncertainty due to COVID-19. The study deliberates on consultations to overcome various such past disruptions and foresees new ones to boost the preparedness. The frameworks help businesses plan their strategic alignments for recovery from such disruptive trends. Further, analysts at TMR helps you break down the complex scenario and bring resiliency in uncertain times.
The report sheds light on various aspects and answers pertinent questions on the market. Some of the important ones are:
1. What can be the best investment choices for venturing into new product and service lines?
2. What value propositions should businesses aim at while making new research and development funding?
3. Which regulations will be most helpful for stakeholders to boost their supply chain network?
4. Which regions might see the demand maturing in certain segments in near future?
5. What are the some of the best cost optimization strategies with vendors that some well-entrenched players have gained success with?
6. Which are the key perspectives that the C-suite are leveraging to move businesses to new growth trajectory?
7. Which government regulations might challenge the status of key regional markets?
8. How will the emerging political and economic scenario affect opportunities in key growth areas?
9. What are some of the value-grab opportunities in various segments?
10. What will be the barrier to entry for new players in the market?
Note: Although care has been taken to maintain the highest levels of accuracy in TMR’s reports, recent market/vendor-specific changes may take time to reflect in the analysis.